Belladonna alkaloids and phenobarbital and Pretomanid Tablets
Determining the interaction of Belladonna alkaloids and phenobarbital and Pretomanid Tablets and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: Coadministration of pretomanid with strong or moderate CYP450 3A4 inducers may decrease the plasma concentrations and antimicrobial effects of pretomanid, which has been shown to be a substrate of the isoenzyme. Following 7 days of concomitant administration, rifampin (600 mg daily) decreased systemic exposure (AUC) and peak plasma concentration (Cmax) of pretomanid by 66% and 53%, respectively. In another 7-day study, efavirenz (600 mg daily) decreased mean AUC and Cmax of pretomanid (200 mg daily) by 35% and 28%, respectively. MANAGEMENT: The use of pretomanid with strong or moderate CYP450 3A4 inducers should be avoided. Dosage adjustments as well as clinical and laboratory monitoring of pretomanid should be considered whenever a strong or moderate CYP450 3A4 inducer is added to or withdrawn from therapy. References "Product Information. Pretomanid (pretomanid)." The Global Alliance for TB Drug Development, New York, NY.
Professional:GENERALLY AVOID: Coadministration of pretomanid with strong or moderate CYP450 3A4 inducers may decrease the plasma concentrations and antimicrobial effects of pretomanid, which has been shown to be a substrate of the isoenzyme. Following 7 days of concomitant administration, rifampin (600 mg daily) decreased systemic exposure (AUC) and peak plasma concentration (Cmax) of pretomanid by 66% and 53%, respectively. In another 7-day study, efavirenz (600 mg daily) decreased mean AUC and Cmax of pretomanid (200 mg daily) by 35% and 28%, respectively.
MANAGEMENT: The use of pretomanid with strong or moderate CYP450 3A4 inducers should be avoided. Dosage adjustments as well as clinical and laboratory monitoring of pretomanid should be considered whenever a strong or moderate CYP450 3A4 inducer is added to or withdrawn from therapy.
- "Product Information. Pretomanid (pretomanid)." The Global Alliance for TB Drug Development, New York, NY.
Generic Name: atropine / hyoscyamine / phenobarbital / scopolamine
Brand name: Donnatal, D-Tal, Phenohytro, Chardonna-2, Hyosophen, Donnapine, Elixiral, Bellatal, Spasmolin, Haponal, Antispas, Barbidonna, Donnatal Extentabs, Antispasmodic, Bellalphen, Donnaphen, Spasquid, Alkabel-SR, Bellatal ER, Servira, PB-Hyos, Quadrapax, Phenobarbital with Belladonna Alkaloids
Synonyms: Hyoscyamine, Atropine, Scopolamine, and Phenobarbital
Generic Name: pretomanid
Brand name:
Synonyms: Pretomanid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Belladonna alkaloids and phenobarbital-Pretz-D
- Belladonna alkaloids and phenobarbital-Prevacid
- Belladonna alkaloids and phenobarbital-Prevacid 24 HR
- Belladonna alkaloids and phenobarbital-Prevacid Injection
- Belladonna alkaloids and phenobarbital-Prevacid Naprapac
- Belladonna alkaloids and phenobarbital-Prevacid OTC
- Pretomanid Tablets-Belladonna and Opium
- Pretomanid Tablets-Belladonna and opium rectal
- Pretomanid Tablets-Belladonna and Opium Suppository
- Pretomanid Tablets-Belladonna Tincture
- Pretomanid Tablets-Belladonna/Phenobarbital
- Pretomanid Tablets-Belrapzo